Chloroprocaine Other names: Nesacaine

Chemical formula: C₁₃H₁₉ClN₂O₂  Molecular mass: 270.755 g/mol  PubChem compound: 8612

Therapeutic indications

Chloroprocaine is indicated for:

Spinal anaesthesia in planned surgical procedure not exceeding 40 minutes

Population group: only adults (18 - 65 years old)

Spinal block

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Femoral block

Population group: only adults (18 - 65 years old)

Femoral nerve block

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Axillary block

Population group: only adults (18 - 65 years old)

at least one of
Brachial plexus block by axillary approach
Local anesthetic axillary compartment block

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Brachial plexus block

Population group: only adults (18 - 65 years old)

Injection of anesthetic agent into brachial plexus

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Sciatic block

Population group: only adults (18 - 65 years old)

Injection of anesthetic agent into sciatic nerve

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Peribulbar block

Population group: only adults (18 - 65 years old)

Peribulbar infiltration of local anesthetic

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Infraorbital block

Population group: only adults (18 - 65 years old)

Infraorbital nerve block

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Chloroprocaine is contraindicated in the following cases:

Serious problems with cardiac conduction

Abnormal cardiac conduction

Severe anaemia in case of intrathecal administration

Anemia

Hypovolemia in case of perineural administration

Hypovolemia

Anticoagulants, congenital or acquired bleeding disorder in case of intrathecal administration

at least one of
Oral anticoagulants
Acquired coagulation disorder
† Congenital von Willebrand's disease
Hereditary coagulation factor deficiency

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2017: AMPRES 10 mg/ml Solution for injection
Summary of Product Characteristics (SPC) 2020: AMPRES 20 mg/ml Solution for injection
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈